Table 3.
Abbreviation | Definition | Description |
---|---|---|
Antioxidant power available in circulationa | ||
ORAC | Oxygen radical absorbance capacity | Comparison: radical scavenging ability of a standard antioxidant e.g. Trolox |
TEAC | Trolox equivalent antioxidant capacity | Comparison: radical scavenging ability of a standard antioxidant e.g. Trolox |
TAS | Total antioxidant status | Trolox, or other relevant antioxidant standard |
FRAP | Ferric-reducing ability of plasma | |
GAE | Gallic acid equivalents | Total polyphenol content using gallic acid as standard |
CE | Catechin equivalents | Similar to previous |
Evidence of lipid peroxidation or potential for lipid peroxidation | ||
LH | Lipid hydroperoxides | Early evidence of lipid peroxidation |
MDA | Malondialdehyde | |
TBARS | Thiobarbituric acid-reactive substances | Including MDA and other byproducts of lipid peroxidation |
IsoP; iP | Isoprostanes | Resulting from free radical oxidation of arachidonic acid |
Evidence of protein oxidation | ||
PC | Protein carbonyls | Determined using 2,4-dinitrophenylhydrazine assay |
CO | Carbonyl groups |
aCould be used to assess the supplement itself (drink or dissolved powder extract)